Per P.
- Country
- Denmark
- Department
- Onkologisk afdeling R, KFE
Research Overview
- Evaluation of [Main Substance] in Combination with Other Agents for Patients with BRAF V600E Mutated Colorectal Cancer
- A Clinical Trial of Pembrolizumab (MK-3475) Evaluating Predictive Biomarkers in Subjects with Advanced Solid Tumors (KEYNOTE-158)
- Phase 3 Multicenter Randomized Study Comparing Efficacy and Safety of Sacituzumab Tirumotecan Versus Physician's Choice in Advanced Gastroesophageal Adenocarcinoma
Data & Insights
Has run more than one trial at 60 of 186 partner sites.
Specializations
Gastrointestinal Oncology
Specializes in investigating treatments for gastric cancer and gastroesophageal junction adenocarcinoma, with particular focus on targeted and combination therapies.
- Advanced gastric cancer management
- HER2-negative gastric treatments
- Neoadjuvant therapeutic approaches
Leads research into innovative treatment strategies combining chemotherapy with immunotherapy for gastrointestinal malignancies.
Colorectal Cancer Research
Focuses on advanced colorectal cancer treatment, particularly in cases with specific genetic mutations such as BRAF V600E and microsatellite instability-high (MSI-H).
- Targeted therapy development
- Neoadjuvant chemotherapy protocols
- Genetic mutation-specific treatments
Investigates personalized treatment approaches based on specific genetic markers and mutation profiles.
Pancreatic Cancer Studies
Conducts research in pancreatic ductal adenocarcinoma treatment, focusing on both resectable and non-resectable cases.
- Adjuvant therapy optimization
- Modified chemotherapy protocols
- Treatment strategies for fragile patients
Explores innovative therapeutic combinations and modified treatment protocols for various patient populations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.